Christian Jonasson

3.1k total citations · 1 hit paper
39 papers, 1.6k citations indexed

About

Christian Jonasson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Christian Jonasson has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Christian Jonasson's work include Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (8 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Christian Jonasson is often cited by papers focused on Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (8 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Christian Jonasson collaborates with scholars based in Norway, United States and Sweden. Christian Jonasson's co-authors include Kristian Hveem, Mads Melbye, Björn Pasternak, Peter Ueda, Björn Eliasson, Soffia Guðbjörnsdóttir, Henrik Svanström, Jan Gunnar Hatlebakk, Stefan Franzén and Ann‐Marie Svensson and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Christian Jonasson

35 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

2024 57 citations Björn Pasternak, Viktor Wintzell et al. BMJ profile →

Peers

Countries citing papers authored by Christian Jonasson

Since Specialization

Citations

This map shows the geographic impact of Christian Jonasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Jonasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Jonasson more than expected).

Fields of papers citing papers by Christian Jonasson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Jonasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Jonasson. The network helps show where Christian Jonasson may publish in the future.

Co-authorship network of co-authors of Christian Jonasson

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Jonasson. A scholar is included among the top collaborators of Christian Jonasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Jonasson. Christian Jonasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study 2025 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), (unknown), Omri Snir, Kristian Hindberg, Sigrid K. Brækkan, Steven P. Grover, Therese Haugdahl Nøst, Péter Gál, Gábor Pál, Christian Jonasson, Peter Garred, Tom Eirik Mollnes, Kristian Hveem, John‐Bjarne Hansen	0
2	Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3) 2025 ·Cancer Management and Research ·(unknown), (unknown), (unknown), Christian Jonasson, Christian Beisland, Tom Børge Johannesen, Oddvar Solli, Jan Oldenburg, D. Heinrich	1
3	Plasma osteopontin levels are associated with the risk of future incident venous thromboembolism—the Trøndelag Health Study (HUNT) 2025 ·Journal of Thrombosis and Haemostasis ·Maryam Hosseini, Kristian Hindberg, Therese Haugdahl Nøst, Christian Jonasson, Kristian Hveem, John‐Bjarne Hansen, Omri Snir	0
4	Synthetic data as external control arms in scarce single-arm clinical trials 2025 ·PLOS Digital Health ·(unknown), (unknown), (unknown), Christian Jonasson, Jan F. Nygård	2
5	Histo–blood group ABO system transferase plasma levels and risk of future venous thromboembolism: the HUNT study 2025 ·Blood ·(unknown), (unknown), David‐Alexandre Trégouët, Therese Haugdahl Nøst, Weihong Tang, Weihua Guan, Christian Jonasson, Pierre‐Emmanuel Morange, Kristian Hindberg, A.R. Folsom, Kristian Hveem, Vânia M. Morelli, John‐Bjarne Hansen	0
6	Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies 2024 ·European Journal of Preventive Cardiology ·Edoardo Bertero, Luca Carmisciano, Christian Jonasson, Javed Butler, Christoph Maack, Pietro Ameri	6
7	Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study 2023 ·Hepatology ·Arvid Engström, Viktor Wintzell, Mads Melbye, Henrik Svanström, Björn Eliasson, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Anders Hviid, Peter Ueda, Björn Pasternak	31
8	Sodium–Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study 2022 ·Diabetes Care ·(unknown), Viktor Wintzell, Mads Melbye, Anders Hviid, Björn Eliasson, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Henrik Svanström, Björn Pasternak, Peter Ueda	22
9	Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation 2021 ·Heart ·(unknown), Christian Jonasson, Waleed Ghanima, (unknown), Sigrun Halvorsen	35
10	Metabolic syndrome and the plasma proteome: from association to causation 2021 ·Cardiovascular Diabetology ·Mohamed A. Elhadad, Rory Wilson, Shaza B. Zaghlool, Cornelia Huth, Christian Gieger, Harald Grallert, Johannes Graumann, Wolfgang Rathmann, Wolfgang Köenig, Moritz F. Sinner, Kristian Hveem, Karsten Suhre, Barbara Thorand, Christian Jonasson, Mélanie Waldenberger, Annette Peters	18
11	Deciphering the Plasma Proteome of Type 2 Diabetes 2020 ·Diabetes ·Mohamed A. Elhadad, Christian Jonasson, Cornelia Huth, Rory Wilson, Christian Gieger, (unknown), Harald Grallert, Johannes Graumann, Valérie Gailus‐Durner, Wolfgang Rathmann, Christine von Toerne, Stefanie M. Hauck, Wolfgang Köenig, Moritz F. Sinner, Tudor I. Oprea, Karsten Suhre, Barbara Thorand, Kristian Hveem, Annette Peters, Mélanie Waldenberger	36
12	Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study 2020 ·BMJ ·Björn Pasternak, Viktor Wintzell, Mads Melbye, Björn Eliasson, Ann‐Marie Svensson, Stefan Franzén, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Henrik Svanström, Peter Ueda	70
13	Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study 2019 ·BMJ ·Björn Pasternak, Peter Ueda, Björn Eliasson, Ann‐Marie Svensson, Stefan Franzén, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Viktor Wintzell, Mads Melbye, Henrik Svanström	77
14	Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study 2018 ·BMJ ·Peter Ueda, Henrik Svanström, Mads Melbye, Björn Eliasson, Ann‐Marie Svensson, Stefan Franzén, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Björn Pasternak	273
15	Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden 2018 ·The Lancet Diabetes & Endocrinology ·Henrik Svanström, Peter Ueda, Mads Melbye, Björn Eliasson, Ann‐Marie Svensson, Stefan Franzén, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Björn Pasternak	56
16	A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants 2016 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, (unknown), Pål Falck, Oddvar Solli, Christian Jonasson	95
17	Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study 2013 ·Scandinavian Journal of Gastroenterology ·Christian Jonasson, Ingunn Fride Tvete, Jan Gunnar Hatlebakk	5
18	Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications 2012 ·European Journal of Gastroenterology & Hepatology ·Christian Jonasson, Jan Gunnar Hatlebakk, Lars Lundell, (unknown), Morten Andersen, Fredrik Granath	7
19	Simultaneous intramuscular pressure and surface electromyography measurement in diagnosing the chronic compartment syndrome 2009 ·Scandinavian Journal of Medicine and Science in Sports ·(unknown), Christian Jonasson, Jorma Styf	18
20	Low‐dose inhaled budesonide once or twice daily for 27 months in children with mild asthma 2000 ·Allergy ·G Jónasson, (unknown), Christian Jonasson, Petter Mowinckel	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact